Navigation Links
Janssen Announces Launch of Authorized Generic for RISPERDAL(R)
Date:6/30/2008

infection, vomiting, coughing, urinary incontinence, increased saliva, constipation, fever, tremors, muscle stiffness, abdominal pain, anxiety, nausea, dizziness, dry mouth, rash, restlessness, and indigestion.

Neuroleptic Malignant Syndrome (NMS) is a rare and potentially fatal side effect reported with RISPERDAL and similar medicines. Call your doctor immediately if the person being treated develops symptoms such as high fever; stiff muscles; shaking; confusion; sweating; changes in pulse, heart rate, or blood pressure; or muscle pain and weakness. Treatment should be stopped if the person being treated has NMS.

Tardive Dyskinesia (TD) is a serious, sometimes permanent side effect reported with RISPERDAL and similar medications. TD includes uncontrollable movements of the face, tongue, and other parts of the body. The risk of developing TD and the chance that it will become permanent is thought to increase with the length of therapy and the overall dose taken by the patient. This condition can develop after a brief period of therapy at low doses, although this is much less common. There is no known treatment for TD, but it may go away partially or completely if therapy is stopped.

RISPERDAL and similar medications can raise the blood levels of a hormone known as prolactin, causing a condition known as hyperprolactinemia. Blood levels of prolactin remain elevated with continued use. Some side effects seen with these medications include the absence of a menstrual period; breasts producing milk; the development of breasts by males; and the inability to achieve an erection. The connection between prolactin levels and side effects is unknown.

High blood sugar and diabetes have been reported with RISPERDAL and similar medications. If the person being treated has diabetes or risk factors such as being overweight or a family history of diabetes, blood sugar testing should be performed at the beginning and throughout treatment. Complications of
'/>"/>

SOURCE Johnson & Johnson
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Marc Feldmann and Sir Ravinder Maini win Dr. Paul Janssen Award for Biomedical Research
2. Researchers who helped millions with arthritis receive prestigious Janssen Award
3. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
4. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
5. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
6. HEI, Inc. Announces Sale of RFID Division Assets
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
8. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
9. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
10. Brooke Franchise Corporation Announces Selected July Results
11. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... As part of Child Passenger Safety Week, which ... Amica Insurance is reminding parents and caregivers ... in the car. , According to a 2012 ... (NHTSA), 20 percent of drivers of child passengers admitted ... child restraints. However, 90 percent of those same drivers ...
(Date:9/16/2014)... PA (PRWEB) September 16, 2014 Former ... well today after undergoing successful heart transplantation surgery at ... Mr. Tekulve, who spent most of his 16-year baseball ... team as a commentator for Root Sports Pittsburgh, was ... transplant surgeon, Stephen Bailey, MD, surgical director of AGH’s ...
(Date:9/16/2014)... everyday, but that doesn,t mean the findings are put ... the neonatal mortality rate is 10 times higher than ... applying an inexpensive topical solution of chlorhexidine to cleanse ... by 24 percent, many Indian parents did not receive ... that we don,t have solutions to solve major societal ...
(Date:9/16/2014)... 2014 A team of researchers at Boston University ... new model to study the motion patterns of bacteria ... relate to communication within a bacterial colony. , The ... bacteria to a microcantilever a microscopic beam anchored ... thus coupling its motion to that of the bacteria. ...
(Date:9/16/2014)... 15, 2014A prospective study that compared patient-reported outcomes ... bone metastases demonstrates that single fraction radiation therapy ... radiation therapy (MFRT) when pain, function and quality ... today at the American Society for Radiation Oncology,s ... that improvements in patients, pain, function and degree ...
Breaking Medicine News(10 mins):Health News:Amica Offers Tips During Child Passenger Safety Week 2Health News:Former Pittsburgh Pirates Pitcher and Baseball Analyst Kent Tekulve Undergoes Successful Heart Transplant at Allegheny General Hospital 2Health News:Former Pittsburgh Pirates Pitcher and Baseball Analyst Kent Tekulve Undergoes Successful Heart Transplant at Allegheny General Hospital 3Health News:Pairing social networks with social motives to close the science gap 2Health News:Pairing social networks with social motives to close the science gap 3Health News:And so they beat on, flagella against the cantilever 2Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 2Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 3Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 4
... rest of nation, , , TUESDAY, Feb. 10 (HealthDay News) -- A ... pain has more than doubled in that state since the early ... in the country as a whole. , "We were actually ... professor of medicine at the University of North Carolina and the ...
... of Americans age 65 and older have prescription drug coverage ... according to a University of Michigan analysis. And poor seniors ... , The analysis compares drug coverage among a nationally ... both in 2004 and after the Medicare Part D prescription ...
... National Leaders in the Effort to Improve Long-Term Care ... SCAN Foundation announced today that two of America,s leading ... for the elderly, Jennie Chin Hansen, R.N., ... named to The SCAN Foundation board of directors.Bruce Chernof, ...
... in Barry Willer,s office at the University at Buffalo was ... a relatively mild traumatic brain injury, and he was doing ... best efforts, the man,s wife described him to friends as ... Willer, UB professor of psychiatry and a specialist in traumatic ...
... Government contract; $28.5 million in contract year one- ... drives revenue for first half- Earnings per share ... Strong balance sheet with $2.1 million in cash, ... Feb. 10 Sharps Compliance Corp. (OTC Bulletin ...
... The Animal Research Minute is a daily report of ... Feb. 10 The Foundation for Biomedical Research (FBR) ... radio broadcast, The Animal Research Minute, nationally after experiencing ... Minute is an educational report of the day,s medical ...
Cached Medicine News:Health News:Chronic Low Back Pain Is on the Rise 2Health News:Chronic Low Back Pain Is on the Rise 3Health News:Most seniors have drug coverage, study shows 2Health News:The SCAN Foundation Names New Members to Its Board 2Health News:The SCAN Foundation Names New Members to Its Board 3Health News:Brain-injured patients can relearn emotions 2Health News:Brain-injured patients can relearn emotions 3Health News:Brain-injured patients can relearn emotions 4Health News:Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results 2Health News:Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results 3Health News:Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results 4Health News:Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results 5Health News:Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results 6Health News:Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results 7Health News:Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results 8Health News:Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results 9Health News:Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results 10Health News:Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results 11Health News:Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results 12Health News:Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results 13Health News:Foundation for Biomedical Research Announces National Distribution of Daily Radio Broadcast 2
(Date:9/16/2014)... Sept. 16, 2014 The Lupus Foundation of ... LLY ) today released results from UNVEIL: understanding the ... on the lupus journey and the challenges not only ... caregivers. The UNVEIL study, which involved over 1,000 people ... lupus has on all aspects of life including family, ...
(Date:9/16/2014)... Sept. 16, 2014 Imprimis Pharmaceuticals, Inc. (Nasdaq: ... to delivering high quality and novel medicines to physicians ... Executive Officer Mark Baum will be a ... Select Conference in New York City.  Mr. Baum will ... Dropless™ campaign in ophthalmology. The presentation is scheduled for ...
(Date:9/16/2014)... -- Relmada Therapeutics, Inc., (OTCBB: RLMD), a clinical-stage company developing ... today that it has entered into an agreement with ... of animal studies for levorphanol, the active ingredient of ... levorphanol.  Gavril Pasternak, MD, PhD, of MSKCC is the ... Pasternak said, "Levorphanol is a unique opioid analgesic that ...
Breaking Medicine Technology:"UNVEIL" Survey Reveals a Life Interrupted by Lupus 2"UNVEIL" Survey Reveals a Life Interrupted by Lupus 3"UNVEIL" Survey Reveals a Life Interrupted by Lupus 4"UNVEIL" Survey Reveals a Life Interrupted by Lupus 5Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 2Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 3Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 4Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for LevoCap ER 2Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for LevoCap ER 3
... WORTH, Texas, March 22, 2012  The Board of Directors of ... innovator in advanced wound care solutions, announced today that Robert ... of the Company.  In addition, Scott A. Haire has resigned ... Executive Officer of the Company, and Deborah Jenkins Hutchinson has ...
... 22, 2012  Argon Medical Devices, Inc. announced today ... catheter, licensed from Rex Medical, LP, designed to ... treatments. "UltraStream provides clinicians with an ... life for their patients," commented George Leondis, President ...
Cached Medicine Technology:Wound Management Technologies Names Robert Lutz, Jr. as New CEO; Buys Back North American Distribution Rights for CellerateRX® Powder 2Wound Management Technologies Names Robert Lutz, Jr. as New CEO; Buys Back North American Distribution Rights for CellerateRX® Powder 3Argon Medical Devices Announces The Launch of a Unique New Chronic Hemodialysis Catheter 2
... ability to fuse multiple image sets in ... for treatment planning and follow-up. ImageFusion aligns ... complementary features of different scan types. Radionics ... so clinicians can capitalize on the unique ...
... Framelink Stereotactic Linking System simplifies planning for ... (DBS). This software integrates multiple patient ... recording data, to assist in charting the ... target location. Framelink interfaces seamlessly with ...
It provides cranial support in either supine or semi-sitting procedures....
Mathews hand drill, with knurled shank and rotating head....
Medicine Products: